308 related articles for article (PubMed ID: 34993728)
1. Analysis of children with Henoch-Schonlein purpura secondary to infection.
Liu C; Luo L; Fu M; Li Z; Liu J
Clin Rheumatol; 2022 Mar; 41(3):803-810. PubMed ID: 34993728
[TBL] [Abstract][Full Text] [Related]
2. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y
J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.
Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ
BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493
[TBL] [Abstract][Full Text] [Related]
4. Modified Sipjeondaebo-tang (JAROTANG) for Henoch-Schonlein purpura nephritis (HSPN): Two case reports.
Cho S; Jang S; Ryu SS; Park S
Explore (NY); 2023; 19(3):439-444. PubMed ID: 36280432
[TBL] [Abstract][Full Text] [Related]
5. Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?
Jelusic M; Sestan M; Cimaz R; Ozen S
Pediatr Rheumatol Online J; 2019 Feb; 17(1):10. PubMed ID: 30819179
[TBL] [Abstract][Full Text] [Related]
6. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity.
Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z
Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770
[TBL] [Abstract][Full Text] [Related]
7. Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children.
Ge W; Wang HL; Sun RP
Eur J Pediatr; 2014 Feb; 173(2):213-8. PubMed ID: 23963627
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
9. The relationship between red cell distribution width and the risk of Henoch-Schönlein purpura nephritis.
Zhu X; Zhang M; Lan F; Wei H; He Q; Li S; Qin X
Br J Biomed Sci; 2018 Jan; 75(1):30-35. PubMed ID: 28990845
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
11. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
Yu M; Song X; Guo J; Feng Q; Tian J
Eur J Pediatr; 2024 Apr; ():. PubMed ID: 38668796
[TBL] [Abstract][Full Text] [Related]
12. Do practical laboratory indices predict the outcomes of children with Henoch-Schönlein purpura?
Ekinci RMK; Balci S; Sari Gokay S; Yilmaz HL; Dogruel D; Altintas DU; Yilmaz M
Postgrad Med; 2019 May; 131(4):295-298. PubMed ID: 31021301
[No Abstract] [Full Text] [Related]
13. Association between red blood cell distribution width and Henoch-Schonlein purpura nephritis.
Xu H; Li W; Mao JH; Pan YX
Medicine (Baltimore); 2017 Jun; 96(23):e7091. PubMed ID: 28591051
[TBL] [Abstract][Full Text] [Related]
14. Value of the modified semiquantitative classification in predicting outcomes in children with Henoch-Schönlein purpura nephritis.
Wang Y; Jiao J; Wan J; Wu D; Zhang G; Chan H; Wang M; Chan X; Yang H; Li Q
Nephrology (Carlton); 2023 Sep; 28(9):495-505. PubMed ID: 37323118
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase gene polymorphisms are associated with a risk of nephritis in Henoch-Schönlein purpura children.
Jiang J; Duan W; Shang X; Wang H; Gao Y; Tian P; Zhou Q
Eur J Pediatr; 2017 Aug; 176(8):1035-1045. PubMed ID: 28593405
[TBL] [Abstract][Full Text] [Related]
16. [Predictive Value of Complete Blood Count and Inflammation Marker on Risk of Recurrence in Children with Henoch-Schönlein Purpura].
Jiang YJ; Song DY; Li JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):837-842. PubMed ID: 37356948
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification.
Çakıcı EK; Gür G; Yazılıtaş F; Eroğlu FK; Güngör T; Arda N; Orhan D; Özalp Ateş FS; Bülbül M
Clin Exp Nephrol; 2019 Jul; 23(7):939-947. PubMed ID: 30895528
[TBL] [Abstract][Full Text] [Related]
18. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Li MM; Liu N; Zhagn M; Xue HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schönlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels.
Zhang J; Zeng H; Wang N; Tian X; Dou W; Shi P
Eur J Pediatr; 2016 Jan; 175(1):49-55. PubMed ID: 26220440
[TBL] [Abstract][Full Text] [Related]
20. Age Related Characteristics Of Children And Adolescent With Henoch Schönlein Purpura And Systems Involvement: An Experience From Tertiary Care Center.
Aziz DA; Siddiqui F; Siddiqui MT
J Ayub Med Coll Abbottabad; 2022; 34(2):336-340. PubMed ID: 35576298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
